Skip to main content
Have a personal or library account? Click to login
Malignant Acanthosis Nigricans, Florid Cutaneous Papillomatosis and Tripe Palms Syndrome Associated with Gastric Adenocarcinoma - a Case Report Cover

Malignant Acanthosis Nigricans, Florid Cutaneous Papillomatosis and Tripe Palms Syndrome Associated with Gastric Adenocarcinoma - a Case Report

Open Access
|Dec 2015

References

  1. 1. Rogers DL. Acanthosis nigricans. Semin Dermatol 1991;10:160-3.
  2. 2. Schwartz RA. Acanthosis nigricans. J Am Acad Dermatol 1994;31(1):1-19.
  3. 3. Kalus AA, Chien AJ, Olerud JE. Diabetes mellitus and other endocrine diseases. In: Wolf K, Goldsmith LA, Katz SI, Gilchrist BA, Paller AS, Leffell DJ, editors. Fitzpatrick’s dermatology in generale medicine. 7edition. New York: Mc Graw Hill Med; 2008. p. 1461-70.
  4. 4. Olek-Hrab K, Silny W, Zaba R, Osmola-Mankowska A, Machiewicz-Wysocka M, Danczak-Pazdrowska A. Co-occurrrence of acanthosis nigricans and bladder adenocarcinoma - case report. Contemp Oncol (Pozn) 2013;17(3):327-30.
  5. 5. Phiske MM. An approach to acanthosis nigricans. Indian Dermatol Online J 2014;5(3):239-49.
  6. 6. Barbato MT, Criado PR, Silva AK, Averbeck E, Guerine MB, Sa NB. Association of acanthosis nigricans and skin tags with insulin resistence. An Bras Dermatol 2012;87(1):97-104.
  7. 7. Munoz-Perez MA, Camacho F. Acanthosis nigricans: a new cutaneous sign in sever atopic dermatitis and Down syndrome. J Eur Acad Dermatol Venereol 2001;15:325-7.
  8. 8. Ceylan C, Alper S, Kilinc I. Leser-Trelat sign. Int J Dermatol 2002;41:687-8.
  9. 9. Pollitzer S. Acanthosis nigricans. In: Unna PG, Morris M, Besnier E, et al, editors. International atlas of rare skin disease. London: HK Lewis and Co; 1891. Chapter 10; p. 1-3.
  10. 10. Janovsky V. Acanthosis nicricans. In: Unna PG, Morris M, Besnier E, et al, editors. International atlas of rare skin diseases. London; HK Lewis and Co; 1891. Chapter 11; p. 4-5.
  11. 11. Brown J, Winkelmann RK. Acanthosis nigricans: a study of 90 cases. Medicine (Baltimore) 1968;47:33-51.
  12. 12. Curth HO. The necessity of distinguishing four types of acanthosis nigricans. In: Jadassohn W, Schirren CG, editors. Proceedings of XIII International Congress of Dermatology; 1967 Jul 31-Aug 5; Munchen, Germany. Berlin: Springer–Verlag; 1968. p. 557-8.
  13. 13. Van Hagen P, Wijnhoven BPL, Torcque LA, Tilanus HW, van Lanschort JJB, Prens EP. Paraneoplastic acanthosis nigricans, Leser-Trelat and tripe palms associated with gastroesophageal junction adenocarcinoma: a case report. J Med Cas 2011;2(5):197-200.
  14. 14. Pavithran K, Karunakaran M, Palit A. Disorders of keratinisation. In: Valia RG, Ameet RV, editors. IADVL textbook of dermatology. 3ed. Munmbai: Bhalani Publ House; 2008. p. 1009-11.
  15. 15. Kondo Y, Umegaki N, Terao M, Murota H, Kimura T, Karayama I. A case of generalized acanthosis nigricans with positive lupus erythematosus-related autoantibodies and antimicrosomal antibody: autoimmune acanthosis nigricans? Case Rep Dermatol 2012;4(1):85-91.
  16. 16. Sawatkar GU, Dogra S, Bhadada SK, Kanwar AJ. Acanthosis nigricans – an uncommon cutaneous adverse effects of a common medication: report of two cases. Indian J Dermatol Venereol Leprol 2013;79:553.
  17. 17. Erickson L, Lipschutz DE, Wrigley W, Kearse WO. A peculiar cutaneous reaction to repeated injections of insulin. JAMA 1969;209:934-5.
  18. 18. Brinca A, Cardoso JC, Brites MM, Tellechea O, Figueiredo A. Florid cutaneous papillomatosis and acanthosis nigricans maligna revealing gastric adenocarcinoma. An Bras Dermatol 2011;86(3):573-7.
  19. 19. Andreev VC. Malignant acanthosis nigricans. Semin Dermatol 1984;3:265-72.
  20. 20. Ortega-Loayza AG, Ramos W, Gutierrez EL, Paz PC, Bobbio L, Galarza C. Cutaneous manifestations of internal malignancies in tertiary health care hospital of a developing country. An Bras Dermatol 2010;85:736-42.
  21. 21. DeWitt CA, Buescher LS, Stone SP. Cutaneous manifestations of internal malignant diseases: cutaneous paraneoplastic syndromes. In: Wolf K, Goldsmith LA, Katz SI, Gilchrist BA, Paller AS, Leffell DJ, editors. Fitzpatrick’s dermatology in general medicine. 7edition. New York: Mc Graw Hill Med; 2008. p. 1493-507.
  22. 22. Jakubovic BD, Sawires HF, Adam DN. Occult cause of paraneoplastic acanthosis nigricans in a patient with known breast DCIS: case and review. Curr Oncol 2012;19(4):e299-302.
  23. 23. Abu-Safieh Y, Khelfa S. Acanthosis nigricans: aA presentation of gastric adenocarcinoma. Arab J Gasroenterol 2011:12:156-7.
  24. 24. Braverman IM. Skin manifestations of internal malinancy. Clin Geriatr Med 2002;18(1):1-19.
  25. 25. Scully C, Hegarty A. The oral cavity and lips. In: Burns T, Breathnac H, Cox N, Griffiths C, editors. Rook’s textbook of dermatology. Oxford: Wiley-Blackwell; 2010; Chapter 69.
  26. 26. Soto Ortiz JA, Amezcua Rosas G, Guardado Luevanos I, Bologna Molina R. Acanthosis nigricans. Manifestaciones bucales. Dermatol Rev Mex 2011;55(1):47-50.
  27. 27. Swineford SL, Drucker CR. Palliative treatment of paraneoplastic acanthosis nigricans and oral florid papillomatosis with retinoids. J Drugs Dermatol 2010;9(9):1151-3.
  28. 28. Schulmann K, Strate K, Pox CP, Wieland U, Kreuter A. Paraneoplastic acanthosis nigricans with cutaneous and mucosal papillomatosis preceding recurrence of a gastric adenocarcinoma. J Clin Oncol 2012;30(32):e325-6.
  29. 29. Amjad M, Arfan-ul-Bari, Shah AA. Malignant acanthosis nigricans: an early diagnostic clue. J Coll Physicians Surg Pak 2010;20(2):127-9.
  30. 30. Pentenero M, Carrozzo M, Pagano M, Gandolfo S. Oral acanthosis nigricans, tripe palms and sign of Leser-Trelat in a patient with gastric adenocarcinoma. Int J Dermatol 2004;43:530-2.
  31. 31. Mukai T. Acanthosis nigricans. Acta Derm (Kyoto) 1929;14:447-60.
  32. 32. Lenzner U, Ramsauer J, Petzoldt W, Meigel W. Acanthosis nigricans maligna. Case report and review of the literature. Hautarzt 1998;49:41-7.
  33. 33. Nair PS, Moorthy P, Suprakasan S, Jayapalan S, Sarin M. Malignant acanthosis nigricans with liver secondaries from an occult primary adenocarcinoma of gastrointestinal tract. Indian J Dermatol Venereol Leprol 2005;71(3):197-8.
  34. 34. Kleikamp S, Bohm M, Frosch P, Brinkmeier T. Acanthosis nigricans, papillomatosis mucosae aund „tripe palms“ in a patient with metastasized carcinoma. Dtsch Med Wochenschr 2006;131(21):1209-13.
  35. 35. Oh CW, Yoon J, Kim CY. Malignant acanthosis nigricans associated with ovarian cancer. Case Rep Dermatol 2010;2(2):103-9.
  36. 36. Kaminska-Winciorek G, Brzezinska-Wcislo L, Lis-Swiety A, Krauze E. Paraneoplastic type of acanthosis nigricans in patient with hepatocellular carcinoma. Adv Med Sci 2007;52:254-6.
  37. 37. Lazzarini R, Simone K, Queiroz G, Courral I, Magliari ME, Feder CK, et al. Acantose nigricante maligna: realato de caso. Dermatol Online J 2014;20(4):22377.
  38. 38. Costa MC, Martinez NS, Belicha MG, Leal F. Acanthosis nigricans and ”tripe palm” as paraneoplastic manifestations of metastatic tumor. An Bras Dermatol 2012;87(3):498-500.
  39. 39. Yang YH, Zhang RZ, Kang DH, Zhu WY. Three paraneoplastic signs in the same patient with gastric adenocarcinoma. Dermatol Online J 2013;19(7):18966.
  40. 40. Stawczyk-Macieja M, Szczerkowska-Dobosz A, Nowicki R, Majewska H, Dubovik M, Sokolowska-Wojdylo M. Malignant acanthosis nigricans, florid cutaneous papillomatosis and tripe palms syndrome associated with gastric adenocarcinoma. Postepy Dermatol Alergol 2014;31(1):56-8.
  41. 41. Kebria MM, Belinson J, Kim R, Mekhail TM. Malignant acanthosis nigricans, tripe palms and sign of Leser-Trelat, a hint to the diagnosis of early stage ovarian cancer: a case report and review of the literature. Gynecol Oncol 2006;101(2):353-5.
  42. 42. Schwartz RP, Burgess GH. Florid cutaneous papillomatosis. Arch Dermatol 1978;114:1803-6.
  43. 43. White H. Acanthosis nigricans and wart like lesions associated with metastatic carcinoma of the stomach. Cutis 1976;17:931-3.
  44. 44. Gross G, Pfister H, Hellenthal B, Hagedom M. Acanthosis nigricans maligna. Clinical and virological investigations. Dermatologica 1984;168:265-72.
  45. 45. Breathnach SM, Wells GC. Acanthosis palmaris: tripe palms. A distinctive pattern of palmar keratoderma frequently associated with internal malignancy. Clin Exp Dermatol 1980;5:181-9.
  46. 46. Cohen PR, Grossman ME, Almeida L, Kurzrock R. Tripe palms and malignancy. J Clin Oncol 1989;7:669-78.
  47. 47. Koulaouzidis A, Leiper K. Tripe palms or acanthosis palmaris. Intern Med J 2007;37:502.
  48. 48. Saeed H, Massarweh S. Images in clinical medicine. Hypertrophic pulmonary osteoarthropathy and tripe palms. N Engl J Med 2012;366(4):360.
  49. 49. Cox NH, Coulsin IH. Systemic diseases and skin. In: Burns DA, Breathnach SM, Cox NH, Grifits CEM, editors. Rook’s textbook of dermatology. Oxford: Blackwell Publishing Ltd; 2010.
  50. 50. Abreu Velez AM, Howard MS. Diagnosis and treatment of cutaneous paraneoplastic disorders. Dermatol Ther 2010;23:662-75.
  51. 51. Clarke J. Malignant acanthosis nigricans. Clin Exp Dermatol 1977;2:167-70.
  52. 52. Moore RL, Devere TS. Epidermal manifestations of internal malignancy. Dermatol Clin 2008;26(1):17-29.
  53. 53. Fabroni C, Gimma A, Cardinali C, Scocco GL. Tripe palms associated with malignant acanthosis nigricans in a patient with gastric adenocarcinoma: a case report and review of the literature. Dermatol Online J 2012;18(11):15.
  54. 54. Heaphy MR, Millns JL, Schroeter AL. The sign of Leser-Trelat in a case of adenocarcinoma of the lung. J Am Acad Dermatol 2000;43(2 Pt 2):386-90.
  55. 55. Haase I, Hunzelmann N. Activation of epidermal growth factor receptor/ERK signaling correlates with suppressed differentiation in malignant acanthosis nigricans. J Invest Dermatol 2002:118(5):891-3.
  56. 56. Ghosh U, Thomas M, Mathai S. Syndrome of insulin resistance with acanthosis nigricans, acral hypertrophy and muscle cramps in an adolescent – a rare diagnosis revised. Indian J Pediatr 2014;81(12):1389-91.
  57. 57. Judge MR, M.Lean WHJ, Munro CS. Disorders of keratinisation. In: Burns DA, Breathnach SM, Cox NA, Griffits CEM, editors. Rook’s Textbook of Dermatology. Oxford: Blackwell Publishing Ltd; 2010. Chapter 19.
  58. 58. Koyama S, Ikeda K, Sato M, Shibahara K, Yuhara K, Fukutomi H, et al. Transforming growth factor-alpha (TGF alpha)-producing gastric carcinoma with acanthosis nigricans: an endocrine effect of TGF alpha in the pathogenesis of cutaneous paraneoplastic syndrome and epithelial hyperplasia of the esophagus. J Gastroenterol 1997;32(1):71-7.
  59. 59. Hida Y, Kubo Y, Nishio Y, Murakami S, Fukumoto D, Sayama K, et al. Malignant acanthosis nigricans with enhanced expression of fibroblast growth factor receptor 3. Acta Derm Venereol 2009;89:435-7.
  60. 60. Akovbyan VA, Talanin NI, Arifov SS, Tukhvatullina ZG, Musabayev AN, Baybekov IM, et al. Successful treatment of acanthosis nigricans with etretinate. J Am Acad Dermatol 1994;31:118-20.
  61. 61. Bohm M, Luger TA, Metze D. Treatment of mixed-type acanthosis nigricans with topical calcipotriol. Br J Dermatol 1998;139:932-4.
  62. 62. Zayed A, Sobhi RM, Abdel Halim DM. Using trichloroacetic acid in the treatment of acanthosis nigricans: a pilot study. J Dermatol Treat 2014;25(3):223-5.
DOI: https://doi.org/10.1515/sjdv-2015-0001 | Journal eISSN: 2406-0631 | Journal ISSN: 1821-0902
Language: English
Page range: 5 - 14
Published on: Dec 10, 2015
Published by: Serbian Association of Dermatovenereologists (SAD)
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2015 Mirjana Paravina, Dragana Ljubisavljević, published by Serbian Association of Dermatovenereologists (SAD)
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.